Summary
The FDA has approved a groundbreaking new pill designed to significantly reduce cholesterol in high-risk patients, offering an alternative to previously expensive injectable drugs.
FDA Approves Novel Pill for Significant Cholesterol Reduction in High-Risk Patients
News Studio
Science
17 July 2026 at 1:25 pm
FDA Approves Novel Pill for Significant Cholesterol Reduction in High-Risk Patients
News Studio
Related & trending news
FDA Approves At-Home Starter Dose for Eisai-Biogen Alzheimer's Drug Leqembi
14 Jul 2026, 9:16 am · Health
FDA Approves Merck's Lipfendra, a Groundbreaking Oral Pill for Cholesterol Reduction
17 Jul 2026, 7:19 am · health
Merck Receives FDA Approval for New Cholesterol-Lowering Drug, Lipfendra
16 Jul 2026, 9:15 pm · Health
F.D.A. Approves New Pill To Slash Cholesterol Levels Beyond Statins
16 Jul 2026, 7:19 pm · medicine
FDA Approves New Cholesterol-Lowering Pill Offering Alternative to Statins
17 Jul 2026, 1:25 pm · Medicine
New Research Suggests Dark Matter May Be 'Tuned In' to a Hidden Fifth Dimension
16 Jul 2026, 11:21 pm · Science